| [1] |
Mort RL, Jackson IJ, Patton EE. The melanocyte lineage in development and disease[J]. Development, 2015, 142(4): 620-632.
|
| [2] |
Cotton CH, Goldberg GN. Evolution of congenital melanocytic nevi toward benignity: A case series[J]. Pediatr Dermatol, 2019, 36(2): 227-231.
|
| [3] |
Charbel C, Fontaine RH, Malouf GG, et al. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi[J]. J Invest Dermatol, 2014, 134(4): 1067-1074.
|
| [4] |
Martins da Silva V, Martinez-Barrios E, Tell-Martí G, et al. Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations[J]. J Invest Dermatol, 2019, 139(4): 900-908.
|
| [5] |
Salgado CM, Basu D, Nikiforova M, et al. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi[J]. Pediatr Dev Pathol, 2015, 18(1): 1-9.
|
| [6] |
Samatar AA, Poulikakos PI. Targeting RAS-ERK signalling in cancer: promises and challenges[J]. Nat Rev Drug Discov, 2014, 13(12): 928-942.
|
| [7] |
Stark MS. Large-Giant Congenital Melanocytic Nevi: Moving Beyond NRAS Mutations[J]. J Invest Dermatol, 2019, 139(4): 756-759.
|
| [8] |
Pawlikowski JS, McBryan T, van Tuyn J, et al. Wnt signaling potentiates nevogenesis[J]. Proc Natl Acad Sci U S A, 2013, 110(40): 16009-16014.
|
| [9] |
Takeo M, Lee W, Rabbani P, et al. EdnrB Governs Regenerative Response of Melanocyte Stem Cells by Crosstalk with Wnt Signaling[J]. Cell Rep, 2016, 15(6): 1291-1302.
|
| [10] |
Chitsazan A, Ferguson B, Villani R, et al. Keratinocyte Sonic Hedgehog Upregulation Drives the Development of Giant Congenital Nevi via Paracrine Endothelin-1 Secretion[J]. J Invest Dermatol, 2018, 138(4): 893-902.
|
| [11] |
Chitsazan A, Ferguson B, Ram R, et al. A mutation in the Cdon gene potentiates congenital nevus development mediated by NRAS(Q61K)[J]. Pigment Cell Melanoma Res, 2016, 29(4): 459-464.
|
| [12] |
Kinsler VA, Anderson G, Latimer B, et al. Immunohistochemical and ultrastructural features of congenital melanocytic naevus cells support a stem-cell phenotype[J]. Br J Dermatol, 2013, 169(2): 374-383.
|
| [13] |
Cramer SF, Fesyuk A. On the development of neurocutaneous units-implications for the histogenesis of congenital, acquired, and dysplastic nevi[J]. Am J Dermatopathol, 2012, 34(1): 60-81.
|
| [14] |
Charbel C, Fontaine RH, Kadlub N, et al. Clonogenic cell subpopulations maintain congenital melanocytic nevi[J]. J Invest Dermatol, 2015, 135(3): 824-833.
|
| [15] |
Ruiz-Maldonado R. Measuring congenital melanocytic nevi[J]. Pediatr Dermatol, 2004, 21(2): 178-179.
|
| [16] |
Krengel S, Scope A, Dusza SW, et al. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi[J]. J Am Acad Dermatol, 2013, 68(3): 441-451.
|
| [17] |
Martins da Silva VP, Marghoob A, Pigem R, et al. Patterns of distribution of giant congenital melanocytic nevi (GCMN): The 6B rule[J]. J Am Acad Dermatol, 2017, 76(4): 689-694.
|
| [18] |
Tannous ZS, Mihm MC Jr, Sober A, et al. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management[J]. J Am Acad Dermatol, 2005, 52(2): 197-203.
|
| [19] |
Simons EA, Huang JT, Schmidt B. Congenital melanocytic nevi in young children: Histopathologic features and clinical outcomes[J]. J Am Acad Dermatol, 2017, 76(5): 941-947.
|
| [20] |
Vergier B, Laharanne E, Prochazkova-Carlotti M, et al. Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During Childhood[J]. JAMA Dermatol, 2016, 152(10): 1147-1151.
|
| [21] |
Yélamos O, Arva NC, Obregon R, et al. A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children[J]. Am J Surg Pathol, 2015, 39(3): 405-415.
|
| [22] |
Viana ACL, Goulart EMA, Gontijo B, et al. A prospective study of patients with large congenital melanocytic nevi and the risk of melanoma[J]. An Bras Dermatol, 2017, 92(2): 200-205.
|
| [23] |
Vourc′h-Jourdain M, Martin L, Barbarot S, et al. Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review[J]. J Am Acad Dermatol, 2013, 68(3): 493-498, e1-e14.
|
| [24] |
Hale EK, Stein J, Ben-Porat L, et al. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registry[J]. Br J Dermatol, 2005, 152(3): 512-517.
|
| [25] |
Kinsler VA, O′Hare P, Bulstrode N, et al. Melanoma in congenital melanocytic naevi[J]. Br J Dermatol, 2017, 176(5): 1131-1143.
|
| [26] |
Marghoob AA, Agero AL, Benvenuto-Andrade C, et al. Large congenital melanocytic nevi, risk of cutaneous melanoma, and prophylactic surgery[J]. J Am Acad Dermatol, 2006, 54(5): 868-870; discussion 871-873.
|
| [27] |
Jakchairoongruang K, Khakoo Y, Beckwith M, et al. New insights into neurocutaneous melanosis[J]. Pediatr Radiol, 2018, 48(12): 1786-1796.
|
| [28] |
Chen Lei, Zhai Liqin, Al-Kzayer Lika′a Fasih Y et al. Neurocutaneous Melanosis in Association With Large Congenital Melanocytic Nevi in Children: A Report of 2 Cases With Clinical, Radiological, and Pathogenetic Evaluation[J]. Front Neurol, 2019, 10: 79.
|
| [29] |
Bekiesińska-Figatowska M, Sawicka E, Zak K, et al. Age related changes in brain MR appearance in the course of neurocutaneous melanosis[J]. Eur J Radiol, 2016, 85(8): 1427-1431.
|
| [30] |
张辉. 不同术式治疗48例巨痣临床应用研究[D]. 乌鲁木齐：新疆医科大学，2019.
|
| [31] |
Mir A, Agim NG, Kane AA, et al. Giant Congenital Melanocytic Nevus Treated With Trametinib[J]. Pediatrics, 2019, 143(3): e20182469.
|
| [32] |
Pawlikowski JS, Brock C, Chen SC, et al. Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling[J]. J Invest Dermatol, 2015, 135(8): 2093-2101.
|
| [33] |
Küsters-Vandevelde HV, Willemsen AE, Groenen PJ, et al. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor[J]. Acta Neuropathol Commun, 2014, 2: 41.
|
| [34] |
Basu D, Salgado CM, Bauer BS, et al. Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway[J]. Neuro Oncol, 2016, 18(4): 528-537.
|
| [35] |
Rouillé T, Aractingi S, Kadlub N, et al. Local Inhibition of MEK/Akt Prevents Cellular Growth in Human Congenital Melanocytic Nevi[J]. J Invest Dermatol, 2019, 139(9): 2004-2015, e13.
|
| [36] |
Polat Ekinci A, Kiliç S, Baykal C. Pigment Loss in Patients with Large Congenital Melanocytic Nevi: Various Clinical Presentations Documented in a Large Series[J]. Pediatr Dermatol, 2016, 33(3): 307-310.
|